An interventional study of Dexamethasone and Bupivacaine in Inguinal Hernia Unilateral, Postoperative Pain and Transversalis Fascia Plane Block, sponsored by Sivas Numune Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Sivas Numune Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 149 studies testing dexamethasone in Pain, Postoperative — 28 open to participants now, 31 under way, 2 of them phase 3. Dexamethasone · Pain, Postoperative.
Among the 149 studies testing dexamethasone in Pain, Postoperative, this one is the 98th largest by planned enrollment, is one of 18 that started in 2026, is one of 38 with no phase, reaches primary completion later than 21 of the 30 other live ones, and was the 149th registered.
5,671 studies on the registry are indexed under Pain, Postoperative; 1,238 are open to participants now.
Browse Pain, Postoperative studies →28 of the 149 studies testing dexamethasone in Pain, Postoperative are open now, in 8 countries. Recruiting first, the newest first:
Ain Shams University · Sites in Egypt
Ages 50–70
Seoul National University Hospital · Sites in Korea, Republic of
Ages 19–79
Marmara University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Beijing Tiantan Hospital · Sites in China
Ages 18–65
Oman Ministry of Health · Sites in Oman
Ages 21–80
By country, each count listing its studies:
Dexamethasone: first FDA approval 1958 (DECADRON), first EMA approval 2010. What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
149 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 11 · Phase 2 14 · Phase 3 19 · Phase 4 75
First in 2005; this study’s year is marked. 18 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 64 is below the median of 75 across 4,841 interventional studies indexed under Pain, Postoperative.
Median enrollment 88 across the 149 interventional studies. Of the 96 that completed or were terminated, 22 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 149 have an industry lead sponsor. The 10 most frequent:
Sivas Numune Hospital is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Sivas Numune Hospital has 2 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
11 of the studies testing dexamethasone in Pain, Postoperative that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07847047Phase 3Assiut UniversitySafety and Efficacy of Dexamethasone Versus Dexmedetomidine as Adjuvants in PENG Block in Hip Surgeries for Postoperative Pain Management | 2027-10 |
| NCT07795281Gaziantep City HospitalIntravenous Dexamethasone Added to Dexmedetomidine After Superior Trunk Block | 2026-12 |
| NCT07380139Ain Shams UniversityDexamethasone vs Dexmedetomidine in Sphenopalatine Ganglion Block for Rhinoplasty Pain | 2026-12-01 |
| NCT07672873Marmara UniversityLocal Dexamethasone Administration in Symptomatic Irreversible Pulpitis | 2026-12-15 |
| NCT07099222University of ArizonaEfficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks | 2026-12-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 149 studies testing dexamethasone in Pain, Postoperative, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Transversalis fascia plane (TFP) block is an ultrasound-guided abdominal wall block used for postoperative analgesia after inguinal hernia repair. Perineural dexamethasone prolongs analgesia in peripheral nerve blocks, but its efficacy in fascial plane blocks, where the injectate reaches the nerves by diffusion, is uncertain, and no placebo-controlled randomized trial has addressed this question for the TFP block. This prospective, randomized, controlled, double-blind trial will evaluate whether adding 4 mg dexamethasone to bupivacaine in a TFP block prolongs the time to first analgesic request and reduces rescue analgesic consumption in adult patients undergoing elective unilateral open inguinal hernia repair under spinal anesthesia. Sixty-four patients will be randomized 1:1 to bupivacaine + dexamethasone or bupivacaine + saline.
Patients scheduled for elective unilateral open inguinal hernia repair under spinal anesthesia (15 mg hyperbaric bupivacaine 0.5%) will be randomized to two groups (n=32 each) using computer-generated random numbers (Research Randomizer). At the end of surgery, a unilateral ultrasound-guided TFP block will be performed (in-plane technique, 21G 100 mm needle, between the transversus abdominis muscle and the transversalis fascia, between the midaxillary line and the iliac crest).
Group D: 20 mL 0.25% bupivacaine + 4 mg (1 mL) dexamethasone. Group K (control): 20 mL 0.25% bupivacaine + 1 mL saline. Total volume is 21 mL in both groups. Study solutions are prepared by an independent anesthesia technician not otherwise involved in the study. The block performer, the postoperative assessor and the patient are blinded to group allocation.
All patients receive 1 g IV paracetamol 20 minutes before the end of surgery and 1000 mg IV paracetamol every 8 hours postoperatively. Rescue analgesia: 50 mg IV dexketoprofen for NRS ≥4 or on patient request; if NRS remains ≥4, 50 mg IV tramadol. Pain (NRS) is assessed at rest and during movement at 2, 4, 8, 12 and 24 hours. Recovery quality is assessed with the Turkish version of the QoR-15 (QoR-15T) preoperatively and at 24 hours. Block-related complications are monitored.
Sample size (G*Power 3.1.9.4; d=0.75, alpha 0.05 two-tailed, power 80%) was 29 per group; increased by 10% for dropouts to 32 per group (N=64). Data will be analyzed with SPSS 23.0 (independent t-test or Mann-Whitney U for continuous variables, chi-square or Fisher's exact test for categorical variables; p\<0.05).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TFP block with 20 mL 0.25% bupivacaine + 4 mg (1 mL) dexamethasone (total 21 mL) at the end of surgery.
Drug: Dexamethasone · Drug: Bupivacaine
TFP block with 20 mL 0.25% bupivacaine + 1 mL 0.9% saline (total 21 mL) at the end of surgery.
Drug: Bupivacaine · Drug: 0.9 % sodium chloride
4 mg (1 mL) added to bupivacaine in the TFP block.
20 mL 0.25% bupivacaine for the TFP block.
1 mL 0.9% saline added to bupivacaine as placebo.
Time to first analgesic request
Time in minutes from completion of the TFP block to the first request for rescue analgesia (dexketoprofen 50 mg IV), given for NRS ≥4 or on patient request.
Time frame: 24 hours postoperatively
VAS pain score at rest
Pain intensity at rest measured with the Visual Analog Scale (VAS, 0 = no pain, 10 = worst imaginable pain).
Time frame: 2, 4, 8, 12 and 24 hours postoperatively
VAS pain score during movement
Pain intensity during movement (coughing or 30° leg raise) measured with the VAS (0-10).
Time frame: 2, 4, 8, 12 and 24 hours postoperatively
Plan to share: No — upon reasonable request
Start is estimated for Nov 2026; primary completion for Feb 2027, 2 months later.
Of 2,101 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 2 months is below that.
Counting every sponsor, half of 2,114 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dexamethasone
Sivas Numune Hospital